Skip to content

Income Tax at other companies

CTO
Citius Oncology, Inc.CTOR
-$231.21K-188%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$12K+50.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$0
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$9K+104%
WHW
Whitehawk Therapeutics, Inc. Common StockWHWK
$0

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+66.4%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateContinuingOperations.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's income tax?
OS Therapies (OSTX) reported income tax of 50% in Q1 2026.
How has OS Therapies's income tax changed year-over-year?
OS Therapies's income tax decreased by 0.0% year-over-year, from 50% to 50%.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.